Andrew Rappaport - Mar 5, 2024 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
Director
Signature
/s/ Shane Kovacs, Attorney-in-Fact
Stock symbol
OLMA
Transactions as of
Mar 5, 2024
Transactions value $
$0
Form type
4
Date filed
3/6/2024, 05:36 PM
Previous filing
Jun 21, 2023
Next filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Other $0 -481K -100% $0.00* 0 Mar 5, 2024 See Footnote F1, F2
transaction OLMA Common Stock Other $0 +386K $0.00 386K Mar 5, 2024 See Footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro rata distribution for no consideration from SPW Investments LLC ("SPWI") to its members. Skyline Public Works, LLC, of which the Reporting Person is a managing member, is the general partner of SPWI.
F2 The shares were held by SPWI.
F3 The shares are held by the Rappaport Family Trust, of which the reporting person is co-trustee.